Bicycle Therapeutics
BCYC
16 hedge funds and large institutions have $98.9M invested in Bicycle Therapeutics in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
2,050% more capital inflows, than outflows
Capital inflows: $5.01M | Capital outflows: $233K
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
14% more funds holding
Funds holding: 14 → 16 (+2)
1.06% more ownership
Funds ownership: 20.33% → 21.39% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.25M |
| 2 |
Renaissance Technologies
New York
|
+$859K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$523K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$288K |
| 5 |
Millennium Management
New York
|
+$47.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$187K |
| 2 |
Squarepoint
New York
|
-$42.1K |
| 3 |
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$4K |
BCYC Hedge Fund Activity: Q2 2020 in Review
16 of the 4,890 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q2 2020, worth a combined $98.9M — up 21% from $81.9M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BCYC positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $3.25M. The largest seller was Victory Capital Management, cutting an estimated $187K.
- 16 institutional investors held Bicycle Therapeutics (BCYC) as of Q2 2020, up from 14 in Q1 2020.
- Funds reported $98.9M of Bicycle Therapeutics stock for Q2 2020, up 21% quarter-over-quarter.
- 4 funds opened new Bicycle Therapeutics positions in Q2 2020 and 2 closed out, a net change of +2 holders.
- The largest Bicycle Therapeutics buyer in Q2 2020 was Fidelity Investments, an estimated $3.25M added.
- The largest Bicycle Therapeutics seller in Q2 2020 was Victory Capital Management, an estimated $187K sold.
Based on aggregated 13F filings for Q2 2020.